Pharmafile Logo
Pharmafocus logo
Advanced Search

metastatic breast cancer

Showing 2 posts of 2 posts found.

EMA extends Avastin breast cancer licence

July 1, 2011
Sales and Marketing avastin, breast cancer, metastatic breast cancer

The EMA has extended the breast cancer licence for Roche’s Avastin after initially restricting the drug’s use. The decision comes …

News

FDA approves Eisai breast cancer drug Halaven

November 16, 2010
Sales and Marketing Cancer, Eisai, FDA, Halaven, Xeloda, breast cancer, eribulin mesylate, metastatic breast cancer

The FDA has approved Eisai’s advanced breast cancer drug Halaven for use in heavily pre-treated breast cancer patients. Halaven (eribulin …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026